Aspirin and Oesophageal haemorrhage - a phase IV clinical study of FDA data
Oesophageal haemorrhage is found among people who take Aspirin, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Aspirin and have Oesophageal haemorrhage. It is created by eHealthMe based on reports of 499,395 people who have side effects when taking Aspirin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
499,395 people reported to have side effects when taking Aspirin.
Among them, 129 people (0.03%) have Oesophageal haemorrhage.
What is Aspirin?
Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 508,184 Aspirin users for its effectiveness, alternative drugs and more.
What is Oesophageal haemorrhage?
Oesophageal haemorrhage (bleeding from oesophagus) is found to be associated with 524 drugs and 296 conditions by eHealthMe.
Number of Aspirin and Oesophageal haemorrhage reports submitted per year:
Time on Aspirin when people have Oesophageal haemorrhage *:
Gender of people who have Oesophageal haemorrhage when taking Aspirin*:
Age of people who have Oesophageal haemorrhage when taking Aspirin *:
Common drugs people take besides Aspirin *:
Common side effects people have besides Oesophageal haemorrhage *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Aspirin and have Oesophageal haemorrhage?Check whether Oesophageal haemorrhage is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
Alternative drugs to, pros and cons of Aspirin:
- Aspirin (508,184 reports)
Oesophageal haemorrhage treatments and more:
- Oesophageal haemorrhage (1,586 reports)
COVID vaccines that are related to Oesophageal haemorrhage:
- Oesophageal haemorrhage in Moderna COVID Vaccine
- Oesophageal haemorrhage in Pfizer BioNTech Covid Vaccine
- Oesophageal haemorrhage in Johnson and Johnson Covid Vaccine
How severe was Oesophageal haemorrhage and when was it recovered:
Expand to all the drugs that have ingredients of aspirin:
Common drugs associated with Oesophageal haemorrhage:
- Aspirin: 129 reports
All the drugs that are associated with Oesophageal haemorrhage:
- Oesophageal haemorrhage (524 drugs)
Common conditions associated with Oesophageal haemorrhage:
All the conditions that are associated with Oesophageal haemorrhage:
- Oesophageal haemorrhage (296 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on aspirin (the active ingredients of Aspirin) and Aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.